Literature DB >> 9370070

Epidemiology, prevention, and early detection of breast cancer.

A J Alberg1, K J Helzlsouer.   

Abstract

Breast cancer is a leading women's health issue. Continued advances in understanding the temporal sequencing of relevant exposures promises to shed light on the continuum of breast carcinogenesis. Oral contraceptive use and the transient increase in risk following childbirth are exposures that affect the near-term risk of breast cancer. The availability of commercial testing for inherited susceptibility to breast cancer has accelerated the need for data to develop sound policy for implementing gene testing. The risks associated with BRCA1 and BRCA2 mutations may be less than previously estimated. Antiestrogens with lesser risks than tamoxifen hold promise for chemoprevention, but await testing. Not enough is known to formulate primary prevention strategies based on lifestyle interventions. Further understanding lifestyle factors that may be involved in the etiology of breast cancer and are amenable to preventive intervention thus remains a top priority, with diet and physical activity of greatest interest.

Entities:  

Mesh:

Year:  1997        PMID: 9370070     DOI: 10.1097/00001622-199711000-00003

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  17 in total

1.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.

Authors:  Liu Cao; Wenmei Li; Sangsoo Kim; Steven G Brodie; Chu-Xia Deng
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

2.  Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.

Authors:  Sang Soo Kim; Liu Cao; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Richard Bachelier; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 3.  The role of BRCA1 in DNA damage response.

Authors:  Jiaxue Wu; Lin-Yu Lu; Xiaochun Yu
Journal:  Protein Cell       Date:  2010-02       Impact factor: 14.870

4.  BRCA1 represses DNA replication initiation through antagonizing estrogen signaling and maintains genome stability in parallel with WEE1-MCM2 signaling during pregnancy.

Authors:  Xiaoling Xu; Eric Chen; Lihua Mo; Lei Zhang; Fangyuan Shao; Kai Miao; Jianlin Liu; Sek Man Su; Monica Valecha; Un In Chan; Hongping Zheng; Mark Chen; Weiping Chen; Qiang Chen; Haiqing Fu; Mirit I Aladjem; Yanzhen He; Chu-Xia Deng
Journal:  Hum Mol Genet       Date:  2019-03-01       Impact factor: 6.150

5.  Impaired skin and mammary gland development and increased gamma-irradiation-induced tumorigenesis in mice carrying a mutation of S1152-ATM phosphorylation site in Brca1.

Authors:  Sang Soo Kim; Liu Cao; Hye Jung Baek; Sung-Chul Lim; Cuiling Li; Rui-Hong Wang; Xiaoling Xu; Kwan Ho Cho; Chu-Xia Deng
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

6.  Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination.

Authors:  Satish Sankaran; Lea M Starita; Aaron C Groen; Min Ji Ko; Jeffrey D Parvin
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Mutation of thyroid hormone receptor-β in mice predisposes to the development of mammary tumors.

Authors:  C J Guigon; D W Kim; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

8.  Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.

Authors:  Sang Soo Kim; Liu Cao; Cuiling Li; Xiaoling Xu; L Julie Huber; Lewis A Chodosh; Chu-Xia Deng
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  Breast self-examination in long-term breast cancer survivors.

Authors:  Peter C Trask; Lynne Pahl; Melinda Begeman
Journal:  J Cancer Surviv       Date:  2008-09-23       Impact factor: 4.442

10.  Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor β in xenograft models.

Authors:  Jeong Won Park; Li Zhao; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.